Advertisement
Canada markets close in 5 hours 9 minutes
  • S&P/TSX

    21,747.32
    -126.40 (-0.58%)
     
  • S&P 500

    5,002.05
    -69.58 (-1.37%)
     
  • DOW

    37,779.43
    -681.49 (-1.77%)
     
  • CAD/USD

    0.7298
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    82.18
    -0.63 (-0.76%)
     
  • Bitcoin CAD

    86,884.88
    -2,439.17 (-2.73%)
     
  • CMC Crypto 200

    1,374.35
    -8.22 (-0.59%)
     
  • GOLD FUTURES

    2,355.80
    +17.40 (+0.74%)
     
  • RUSSELL 2000

    1,967.73
    -27.70 (-1.39%)
     
  • 10-Yr Bond

    4.7140
    +0.0620 (+1.33%)
     
  • NASDAQ

    15,440.82
    -271.92 (-1.73%)
     
  • VOLATILITY

    16.94
    +0.97 (+6.07%)
     
  • FTSE

    8,063.19
    +22.81 (+0.28%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6808
    -0.0011 (-0.16%)
     

Jazz Pharmaceuticals: How It’s Positioned before 1Q18

Jazz Pharmaceuticals: How It’s Positioned before 1Q18

In 4Q17, Jazz Pharmaceuticals (JAZZ) generated revenues of $436.4 million compared to $396.6 in 4Q16, which reflected a 10% growth on a YoY (year-over-year) basis and a 6% growth quarter-over-quarter.